#Roche presented its late stage pipeline today at #JPM20, with #tecentriq heading up #oncology with six anticipated indications, including expansions in #HCC, #TNBC, #bladdercancer, #melanoma, #ovariancancer, and #NSCLC. In what other indications and patient segments is tecentriq being tested? #Kognitic‘s platform makes this information accessible in real-time for clients curious about what is next for this momentum-building asset! See image below for #insights into tecentriq’s pipeline.

#Oncology #RealTimeData #Cancer #JPM2020 #Pipeline #AI #RealTimeAnalytics #JPMweek #CompetitiveIntelligence